People using Wegovy, a GLP-1 agonist approved by the US Food and Drug Administration for weight loss, may be about five times at risk of developing eye stroke that can lead to sight loss, compared to users of Ozempic, according to an alarming study
A new side effect, dysesthesia (abnormal skin sensations like tingling or burning), emerged in Phase 3 trials at rates of 8.8% (9mg) to 20.9% (12mg)
The FDA has identified serious adverse events associated with CJC-1295, including increased heart rate and systemic vasodilatory reaction
Let us help you navigate your health journey with trusted, professional guidance.
I was an eagle, hatched to fly where I wanted, a woman on a journey who arrived a thousand times to blunt the blade of cruelty, to scald her eyes with angers fire because she could not accept the sorrow of life, was unprepared to hear childrens voices in the soft evening breeze speak of slaughters carried out by soldiers along the New Mexico border
OSAS has a high prevalence and significant adverse consequences